Idiopathic Pulmonary Hemosiderosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Idiopathic Pulmonary Hemosiderosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT05937191

Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children

The goal of this clinical trial is to compare Leflunomide in Idiopathic pulmonary hemosiderosis. The main questions it aims to answer are: * The efficacy and s…

China34 participantsStarted 2023-06-01

Treatment: Leflunomide, Steroid Drug

All recent trials (2 shown)

UnknownEarly Phase 1

NCT02985346

Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis

Pulmonary hemosiderosis (PH) is a pulmonary hemosiderin deposition which caused by alveolar capillary hemorrhage. PH is easy to recurrent and can lead to pulmon…

Location not specified100 participantsStarted 2017-01

Treatment: Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis